58483-98-0

Basic information

• Product Name: 2-AMINO-5-BROMONICOTINAMIDE
• Synonyms: 2-aMino-5-broMopyridine-3-carboxaMide
• CAS NO: 58483-98-0
• Molecular Formula: C6H6BrN3O
• Molecular Weight: 216.03534
• Mol File: 58483-98-0.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: 2-AMINO-5-BROMONICOTINAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-AMINO-5-BROMONICOTINAMIDE(58483-98-0)
• EPA Substance Registry System: 2-AMINO-5-BROMONICOTINAMIDE(58483-98-0)

Safety Data

• Hazardous Substances Data: 58483-98-0(Hazardous Substances Data)

Usage

General Description

2-Amino-5-Bromonicotinamide is a chemical compound primarily recognized for its role in organic synthesis and pharmaceutical industry. It is classified under the category of organic compounds called bromoamines. Its chemical formula is C6H5BrN2O. Key chemical parameters include a molecular weight of about 214.024 g/mol and it appears as a solid in its pure form. Extreme precaution should be taken while handling this chemical as it could be harmful or unsafe. The details about its solubility, boiling point, melting point, and specific optical rotation vary and should be explored as per individual requirement.

Upstream product

• 5345-47-1 2-aminopyridin-3-carboxylic acid 
• 52833-94-0 2-amino-5-bromonicotinicacid 
• 52963-33-4 2-amino-5-bromonicotinic acid hydrobromide 

Downstream Products

• 142168-97-6 6-bromopyrido<2,3-d>pyrimidine-2,4-dione 

Relevant articles and documents

SUBSTITUTED QUINAZOLINONE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR4

The present invention relates to novel quinazolinone derivatives of formula (I) as well as pharmaceutical compositions containing these compounds. The compounds of formula (I) as provided herein can act as positive allosteric modulators of metabotropic glutamate receptor subtype 4 (mGluR4), and can thus be used as therapeutic agents, particularly in the treatment or prevention of conditions associated with altered glutamatergic signalling and/or functions or conditions which can be affected by alteration of glutamate level or signalling.

SUBSTITUTED BENZOFURAN COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

Disclosed are compounds of formula (I) that are useful as hepatitis C virus (HCV) NSSB polymerise inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NSSB polymerise activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.